论文部分内容阅读
:[目的]了解卵巢转移瘤的临床特征 ,探讨其治疗和预后。[方法]对1985年～1996年109例卵巢转移瘤病人进行回顾性分析。[结果]109例卵巢转移瘤占同期收治的卵巢恶性肿瘤的9 7% ,双侧卵巢转移占62 4% ,单侧卵巢转移占37 6% ,伴腹腔转移占71 6%。1年生存率5 0% ,平均生存时间13个月。来源于乳腺癌、淋巴瘤和生殖道癌的卵巢转移瘤平均生存时间为27个月、32个月和22个月 ,来源于结肠癌、胃癌和肺癌的平均生存时间为9个月、8个月和3个月。肿瘤局限在盆腔内的平均生存时间比腹盆腔广泛转移的明显延长(21个月比9个月) ,有显著的统计学意义(P<0 01)。胃肠道和生殖道癌卵巢转移术后残存肿瘤的直径<2cm(理想肿瘤细胞减灭术)的平均生存时间明显长于>2cm者 ,亦有显著的统计学意义(P<0 01)。[结论]卵巢转移瘤常合并腹盆腔广泛转移 ,预后差 ,但手术达理想减瘤者可以明显延长生存
: [Objective] To investigate the clinical features of ovarian metastases and to explore its treatment and prognosis. [Methods] A total of 109 ovarian metastases from 1985 to 1996 were retrospectively analyzed. [Results] 109 cases of ovarian metastases accounted for 97% of ovarian malignancies treated at the same period, 62 4% of bilateral ovarian metastases, 37 6% of unilateral ovarian metastases, and 71 6% of patients with abdominal metastasis. 1-year survival rate of 50%, the average survival time of 13 months. The average survival time of ovarian metastases from breast cancer, lymphoma and genital tract cancer was 27 months, 32 months and 22 months, and the average survival time of colon cancer, gastric cancer and lung cancer was 9 months and 8 Month and 3 months. The mean survival time of the tumor confined within the pelvis was significantly longer than that of the extensive peritoneal metastasis (21 months vs. 9 months), with significant statistical significance (P <0.01). The average survival time of residual tumor less than 2 cm in diameter (ideal cytoreductive surgery) after ovarian metastasis of gastrointestinal and reproductive cancer was significantly longer than> 2 cm (P <0.01). [Conclusion] Ovarian metastases are often associated with extensive abdominal pelvic metastasis, the prognosis is poor, but the surgery of the ideal reduction of the tumor can significantly prolong survival